Q2 2024 Aveanna Healthcare Holdings Inc Earnings Call Transcript
Key Points
- Aveanna Healthcare Holdings Inc (AVAH) reported a 7% increase in revenue for Q2 2024, reaching approximately $505 million.
- Adjusted EBITDA for the second quarter was $45.6 million, representing a 27.3% increase over the prior year period.
- The company secured double-digit rate improvements in Georgia and Massachusetts, effective the second half of 2024.
- Aveanna added five additional preferred payer agreements, increasing their total to 19, which supports their strategic growth initiatives.
- The company has ample liquidity with $269 million available, providing room to operate and invest in growth opportunities.
- Aveanna continues to face challenges in the labor market, impacting their ability to fully capitalize on demand.
- The company is experiencing ongoing wage pressures in the labor markets, which could affect profitability.
- California remains a challenging landscape for securing funding for appropriate PDN rate increases.
- Q3 is expected to experience softness in core volumes due to summer seasonality and holidays, impacting EBITDA.
- Aveanna's Home Health & Hospice segment saw a 1.4% decrease in revenue compared to the prior year.
Good morning and welcome to Aveanna Healthcare Holdings second-quarter 2024 earnings conference call. Todayâs call is being recorded, and we have allocated 1 hour for prepared remarks and Q&A.
At this time, Iâd like to turn the call over to Debbie Stewart, Aveannaâs Chief Accounting Officer. Thank you. You may begin.
Good morning, and welcome to Aveannaâs second quarter 2024 earnings call. I am Debbie Stewart, the companyâs Chief Accounting Officer. With me today is Jeff Shaner, our Chief Executive Officer; and Matt Buckhalter, our Chief Financial Officer.
During this call, we will make forward-looking statements. Risk factors that may impact those statements and could cause actual future results to differ materially from currently projected results are described in this morningâs press release and the reports we file with the SEC. The company does not undertake any duty to update such forward-looking statements.
Additionally, during todayâs call,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
